Stress Response Functions of ADAR1 Regulated by MAP Kinases
MAP 激酶调控 ADAR1 的应激反应功能
基本信息
- 批准号:10093094
- 负责人:
- 金额:$ 37.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsADAR1AdenosineAdultAffinityAffinity ChromatographyAmino AcidsAntibodiesApoptosisApoptoticBindingBiological ProcessCellular StressCessation of lifeCodeComplexCytoplasmDNA DamageDRADA2b proteinDouble-Stranded RNAEctopic ExpressionElementsEmbryoEmbryonic DevelopmentEpitopesFamily memberGene Expression AlterationGene FamilyGenesInosineInterferonsKnock-inKnockout MiceKnowledgeLifeLuciferasesMAP2K6 geneMAPK1 geneMalignant NeoplasmsMediatingMessenger RNAMicroRNAsMitogen-Activated Protein KinasesMusMutant Strains MiceNuclearNuclear ExportOncogenicPhenotypePhosphorylationProcessProtein IsoformsProteinsRNARNA BindingRNA EditingRNA-specific adenosine deaminase 3RPS6KA5 geneResearchRetrotransposonRibonucleasesRoleSerineShort Interspersed Nucleotide ElementsSignal TransductionStreptavidinStressStructureSystemThreonineTranscriptUntranslated RNAadenosine deaminaseaptamerbiological adaptation to stresscell injurydesignenvironmental changeexperimental studyexportin 5knock-downmRNA Decaymutantp38 Mitogen Activated Protein Kinasepre-miRNAprevent
项目摘要
PROJECT SUMMARY
RNA editing that converts adenosine to inosine (A-to-I RNA editing) specifically in double-stranded RNAs
(dsRNAs) is catalyzed by adenosine deaminases acting on RNA (ADARs). We pioneered in the field of A-to-I
RNA editing by identifying the first ADAR gene family member, ADAR1. Although ADAR1 edits select protein
coding sequences, its most common targets are non-coding sequences consisting of inverted repeats of
retrotransposon elements such as Alu and SINE. There are two ADAR1 isoforms, one, mainly nuclear
localized ADAR1p110, and the other, mostly cytoplasmic ADAR1p150. Furthermore, it seems that there are
RNA editing-dependent and -independent functions of ADAR1.
We recently discovered a new RNA editing-independent function of ADAR1. Stress-induced
phosphorylation of three threonines and two serines of ADAR1 by MKK6-p38-MSK1/2 MAP kinases increased
the binding affinity of ADAR1p110 to Exportin-5 (Xpo5) and its nuclear export mediated by the Xpo5/RanGTP
system. Once translocated to the cytoplasm, ADAR1p110 promoted survival of stressed cells by protecting
anti-apoptotic gene transcripts carrying 3'UTR Alu dsRNA from Staufen1/UPF1-mediated mRNA decay (SMD).
In this application, we will explore this newly found stress response function of ADAR1. Using a
Luciferase expression construct carrying 3'UTR streptavidin-binding RNA aptamers and Alu-dsRNA structure,
we will identify the ribonuclease that degrades the stress response SMD target mRNAs, which are otherwise
protected by ADAR1. We will characterize the ribonuclease activity and its role in the stress induced SMD
mechanism. We will then identify “cargo” dsRNAs, which are exported to the cytoplasm together with the
phosphorylated ADAR1p110 by a sequential affinity chromatography using differentially epitope-tagged Xpo5,
RanQ96L, and phosphomimetic ADAR1p110 expression constructs. We will determine the function of the
dsRNAs in the stress response mechanism by their ectopic expression and knock down experiments. ADAR1
null embryos die at E11-12 due to widespread apoptosis. Using antibodies specific to the ADAR1
phosphorylated at T808, T811, S814, S823, and S825, we will determine when and where the stress induced
ADAR1 phosphorylation occurs during embryonic development. We will then create and conduct phenotypic
analysis of new ADAR1 knockin mutant mouse lines, ADAR1-T/S-to-A and ADAR1-T/S-to-D. ADAR1-T/S-to-A
mice express solely ADAR1-T/S-to-A non-phosphorylatable mutant proteins, whereas ADAR1-T/S-to-D mice
express solely phosphomimetic ADAR1 proteins. By comparing phenotypic differences among these new
mutant mouse strains, we will evaluate the importance of the ADAR1 stress response function during embryo
development and in adult life. Apoptosis of stressed and DNA-damaged cells is one way to prevent their
transformation to cancers, and, thus, the stress response function of ADAR1 is very likely to be relevant to
oncogenic transformation process.
项目概要
RNA 编辑可将腺苷转化为肌苷(A-to-I RNA 编辑),特别是在双链 RNA 中
(dsRNA) 由作用于 RNA (ADAR) 的腺苷脱氨酶催化,我们是 A-to-I 领域的先驱。
通过识别第一个 ADAR 基因家族成员 ADAR1 进行 RNA 编辑,尽管 ADAR1 编辑选择的蛋白质。
编码序列,其最常见的目标是由反向重复组成的非编码序列
逆转录转座子元件如 Alu 和 SINE 有两种 ADAR1 亚型,一种主要是核亚型。
局部 ADAR1p110,另一个主要是细胞质 ADAR1p150 此外,似乎还有。
ADAR1 的 RNA 编辑依赖和独立功能。
我们最近发现了 ADAR1 的一种新的独立于 RNA 编辑的功能。
MKK6-p38-MSK1/2 MAP 激酶对 ADAR1 的三个苏氨酸和两个丝氨酸的磷酸化增加
ADAR1p110 与 Exportin-5 (Xpo5) 的结合亲和力及其由 Xpo5/RanGTP 介导的核输出
一旦转移到细胞质,ADAR1p110 通过保护来促进应激细胞的存活。
抗凋亡基因转录本携带来自 Staufen1/UPF1 介导的 mRNA 衰减 (SMD) 的 3'UTR Alu dsRNA。
在此应用中,我们将使用 ADAR1 来探索新发现的应激反应功能。
携带3'UTR链霉亲和素结合RNA适体和Alu-dsRNA结构的荧光素酶表达构建体,
我们将鉴定能够降解应激反应 SMD 目标 mRNA 的核糖核酸酶,否则这些核糖核酸酶
我们将表征核糖核酸酶活性及其在应激诱导的 SMD 中的作用。
然后我们将识别“货物”dsRNA,它们与 dsRNA 一起输出到细胞质。
使用差异表位标记的 Xpo5,通过连续亲和层析磷酸化 ADAR1p110,
我们将确定 RanQ96L 和拟磷 ADAR1p110 表达构建体的功能。
通过异位表达和 ADAR1 敲低实验研究 dsRNA 在应激反应机制中的作用。
由于使用 ADAR1 特异性抗体,无效胚胎在 E11-12 时死亡。
T808、T811、S814、S823 和 S825 被磷酸化,我们将确定何时何地诱发应激
ADAR1 磷酸化发生在胚胎发育过程中,然后我们将创建并进行表型。
分析新的 ADAR1 敲入突变小鼠系 ADAR1-T/S-to-A 和 ADAR1-T/S-to-D。
小鼠仅表达 ADAR1-T/S-to-A 非磷酸化突变蛋白,而 ADAR1-T/S-to-D 小鼠
通过比较这些新的表型差异,仅表达拟磷 ADAR1 蛋白。
突变小鼠品系,我们将评估 ADAR1 应激反应功能在胚胎过程中的重要性
应激和 DNA 损伤细胞的凋亡是预防其发生的一种方法。
ADAR1的应激反应功能很可能与癌症的转化有关
致癌转化过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAZUKO NISHIKURA其他文献
KAZUKO NISHIKURA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAZUKO NISHIKURA', 18)}}的其他基金
Stress Response Functions of ADAR1 Regulated by MAP Kinases
MAP 激酶调控 ADAR1 的应激反应功能
- 批准号:
10330572 - 财政年份:2019
- 资助金额:
$ 37.51万 - 项目类别:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
EB 病毒 microRNA 控制乳腺癌转移
- 批准号:
8625434 - 财政年份:2014
- 资助金额:
$ 37.51万 - 项目类别:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
EB 病毒 microRNA 控制乳腺癌转移
- 批准号:
9187428 - 财政年份:2014
- 资助金额:
$ 37.51万 - 项目类别:
Control of Cardiogenesis by microRNA Editing
通过 microRNA 编辑控制心脏发生
- 批准号:
7934485 - 财政年份:2009
- 资助金额:
$ 37.51万 - 项目类别:
Control of Cardiogenesis by microRNA Editing
通过 microRNA 编辑控制心脏发生
- 批准号:
7810127 - 财政年份:2009
- 资助金额:
$ 37.51万 - 项目类别:
Control of Cardiogenesis by microRNA Editing
通过 microRNA 编辑控制心脏发生
- 批准号:
7810127 - 财政年份:2009
- 资助金额:
$ 37.51万 - 项目类别:
Control of Cardiogenesis by microRNA Editing
通过 microRNA 编辑控制心脏发生
- 批准号:
7934485 - 财政年份:2009
- 资助金额:
$ 37.51万 - 项目类别:
Functions of ADARI RNA Editase in Erythropoiesis
ADARI RNA 编辑酶在红细胞生成中的功能
- 批准号:
6833858 - 财政年份:2002
- 资助金额:
$ 37.51万 - 项目类别:
Functions of ADARI RNA Editase in Erythropoiesis
ADARI RNA 编辑酶在红细胞生成中的功能
- 批准号:
6746917 - 财政年份:2002
- 资助金额:
$ 37.51万 - 项目类别:
相似海外基金
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
利用公共基因组和转录组数据揭示癌症-RNA 编辑关系
- 批准号:
10453867 - 财政年份:2022
- 资助金额:
$ 37.51万 - 项目类别:
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
利用公共基因组和转录组数据揭示癌症-RNA 编辑关系
- 批准号:
10643949 - 财政年份:2022
- 资助金额:
$ 37.51万 - 项目类别:
Stress Response Functions of ADAR1 Regulated by MAP Kinases
MAP 激酶调控 ADAR1 的应激反应功能
- 批准号:
10330572 - 财政年份:2019
- 资助金额:
$ 37.51万 - 项目类别:
Novel mechanism of smooth muscle phenotypic modulation and vascular remodeling
平滑肌表型调节和血管重塑的新机制
- 批准号:
8653749 - 财政年份:2014
- 资助金额:
$ 37.51万 - 项目类别:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
EB 病毒 microRNA 控制乳腺癌转移
- 批准号:
8625434 - 财政年份:2014
- 资助金额:
$ 37.51万 - 项目类别: